MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS PARIETEX; MESH, SURGICAL, POLYMERIC

Model Number TECT1510ADPR

Device Problems Degraded (1153); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)

Patient Problems Abdominal Pain (1685); Adhesion(s) (1695); Atrial Fibrillation (1729); Erosion (1750); Granuloma (1876); Hemorrhage/Bleeding (1888); Inflammation (1932); Ischemia (1942); Nausea (1970); Necrosis (1971); Pain (1994); Perforation (2001); Tachycardia (2095); Vomiting (2144); Hernia (2240); Injury (2348); Obstruction/Occlusion (2422); Ascites (2596); Weight Changes (2607); Bowel Perforation (2668); No Code Available (3191); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)

Event Type  Injury  

Manufacturer Narrative

(b)(4).If information is provided in the future, a supplemental report will be issued.

Event Description

The patient¿s attorney alleged a deficiency against the device.The product was used for laparoscopic therapeutic treatment of an inguinal hernia.It was reported that after the implant, the patient experienced hardened mesh, mesh erosion, perforated bowel, recurrence, volvulus, ascites, adhesions, granuloma, abdominal pain, nausea, vomiting, tachycardia, atrial fibrillation, ischemic bowel, and necrotic bowel.Post-operative patient treatment included revision surgery, bowel resection, antrectomy of 180 cm of small bowel with side-to-side antiperistaltic anastomosis of jejunum to ascending colon, incidental appendectomy, transferred to the icu, and partial removal of mesh.

Manufacturer Narrative

Additional information: b5, d8, e1(facility name, street1, city, region, postal code), g1(mfr contact first name, last name, street1, mfr city, region, postal code, email, phone number), g3, h6 medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.

Event Description

The patient¿s attorney alleged a deficiency against the device.The product was used for laparoscopic therapeutic treatment of an inguinal hernia.It was reported that after the implant, the patient experienced hardened mesh, mesh erosion, perforated bowel, recurrence, volvulus caused by tethering of bowel, ascites, adhesions, granuloma, abdominal pain, nausea, vomiting, tachycardia, atrial fibrillation, ischemic bowel, internal hernia, pain and necrotic bowel.Post-operative patient treatment included revision surgery, bowel resection, antrectomy of 180 cm of small bowel with side-to-side antiperistaltic anastomosis of jejunum to ascending colon, incidental appendectomy, ttransferred to the icu, and partial removal of mesh.

Manufacturer Narrative

Ime 2402: malnutrition.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.

Event Description

The patient¿s attorney alleged a deficiency against the device.The product was used for laparoscopic therapeutic treatment of an inguinal hernia.It was reported that after the implant, the patient experienced hardened mesh, mesh erosion, perforated bowel, recurrence, volvulus caused by tethering of bowel, ascites, adhesions, granuloma, abdominal pain, nausea, vomiting, tachycardia, atrial fibrillation, ischemic bowel, internal hernia, pain, free fluid in the abdomen, hemorrhagic necrosis, inflammation, obstruction, bleeding, perforation, expulsion of food, malnutrition, weight loss, and necrotic bowel.Post-operative patient treatment included revision surgery, bowel resection, antrectomy of 180 cm of small bowel with side-to-side antiperistaltic anastomosis of jejunum to ascending colon, incidental appendectomy, transferred to the icu, ct scan, use of drain, ventilator use, and partial removal of mesh.

• Brand Name: PARIETEX
• Type of Device: MESH, SURGICAL, POLYMERIC
• Manufacturer (Section D): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer (Section G): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer Contact: justin ellis ; 5920 longbow drive; 8200 coral sea st ne; mounds view,mn, CT 55112 ; 7635265677
• MDR Report Key: 9929605
• MDR Text Key: 186590205
• Report Number: 9615742-2020-00806
• Device Sequence Number: 1
• Product Code: FTL
• UDI-Device Identifier: 10884521180222
• UDI-Public: 10884521180222
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: K982532
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Consumer
• Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup,Followup
• Report Date: 10/04/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 08/31/2020
• Device Model Number: TECT1510ADPR
• Device Catalogue Number: TECT1510ADPR
• Device Lot Number: SPI0170X
• Was Device Available for Evaluation?: No
• Initial Date Manufacturer Received: 03/18/2020
• Initial Date FDA Received: 04/06/2020
• Supplement Dates Manufacturer Received: 11/17/2021; 09/28/2022
• Supplement Dates FDA Received: 12/09/2021; 10/04/2022
• Date Device Manufactured: 09/12/2015
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Hospitalization; Required Intervention; Life Threatening
• Patient Sex: Female
• Patient Weight: 57 KG